These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 33440053)

  • 1. Comprehensive analysis of prohibited substances and methods in sports: Unveiling trends, pharmacokinetics, and WADA evolution.
    Oleksak P; Nepovimova E; Valko M; Alwasel S; Alomar S; Kuca K
    Environ Toxicol Pharmacol; 2024 Jun; 108():104447. PubMed ID: 38636744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual banned-substance review 16
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2024 Jan; 16(1):5-29. PubMed ID: 37985429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the hair detectability of prohibited substances in sports: an in vivo-in silico-clinical approach and analytical implications compared with plasma, urine, and faeces.
    Hung SH; Kan HL; Tung CW; Lin YC; Chen TT; Tian C; Chang WC
    Arch Toxicol; 2024 Mar; 98(3):779-790. PubMed ID: 38224356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breaking Boundaries: Exploring Performance Enhancement and Anti-Doping Testing in Sports.
    Metushi IG; Wagner A; Ahrens B; Ericsson M; Rabin O; Sobolevsky T; Tygart TT
    Clin Chem; 2024 Jul; 70(7):897-904. PubMed ID: 38965701
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of RNA biomarkers in the antidoping field.
    Loria F; Grabherr S; Kuuranne T; Leuenberger N
    Bioanalysis; 2024; 16(10):475-484. PubMed ID: 38497758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid investigating of phase I metabolites of SR9009 in vitro horse liver microsomes via feature-based molecular networking approach: Potential applications in doping control.
    Kwak YB; Yoon J; Yoo HH
    J Pharm Biomed Anal; 2024 Aug; 246():116190. PubMed ID: 38735208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in SARMs anti-doping analysis.
    Slíž K; Mikuš P
    Drug Test Anal; 2024 May; ():. PubMed ID: 38706416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interest of nail clipping tests to discriminate a tail end of a doping regimen from a contamination in case of challenging an adverse analytical finding: Case reports involving ostarine.
    Kintz P; Gheddar L; Ameline A
    Drug Test Anal; 2024 May; 16(5):515-517. PubMed ID: 37718535
    [No Abstract]   [Full Text] [Related]  

  • 9. Untargeted Detection of HIF Stabilizers in Doping Samples: Activity-Based Screening with a Stable In Vitro Bioassay.
    Janssens LK; De Wilde L; Van Eenoo P; Stove CP
    Anal Chem; 2024 Jan; 96(1):238-247. PubMed ID: 38117670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical advances in horseracing medication and doping control from 2018 to 2023.
    Gray B; Lubbock K; Love C; Ryder E; Hudson S; Scarth J
    Drug Test Anal; 2024 Jul; ():. PubMed ID: 39010718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration and detection of a multi-target rAAV gene doping vector in horses using multiple matrices and molecular techniques.
    Maniego J; Harding C; Habershon-Butcher J; Hincks P; Ryder E
    Gene Ther; 2024 Jul; ():. PubMed ID: 38972888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 41
    Thevis M
    Drug Test Anal; 2023; 15(11-12):1310-1311. PubMed ID: 37933681
    [No Abstract]   [Full Text] [Related]  

  • 13. Does a hair test allow discriminating a tail end of a doping regimen from a contamination in case of challenging an anti-doping rule violation? II. Case report involving chlortalidone.
    Kintz P; Gheddar L
    Drug Test Anal; 2023 Dec; ():. PubMed ID: 38128574
    [No Abstract]   [Full Text] [Related]  

  • 14. Sample Preparation Techniques for Growth-Promoting Agents in Various Mammalian Specimen Preceding MS-Analytics.
    Klöppner L; Harps LC; Parr MK
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38257243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance assessment of an equine metabolomics model for screening a range of anabolic agents.
    Cloteau C; Dervilly G; Loup B; Delcourt V; Kaabia Z; Bagilet F; Groseille G; Dauriac K; Fisher S; Popot MA; Garcia P; Le Bizec B; Bailly-Chouriberry L
    Metabolomics; 2023 Apr; 19(4):38. PubMed ID: 37027080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doping in Racing Pigeons (
    Marlier D
    Vet Sci; 2022 Jan; 9(2):. PubMed ID: 35202294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doping detection in animals: A review of analytical methodologies published from 1990 to 2019.
    Moreira F; Carmo H; Guedes de Pinho P; Bastos ML
    Drug Test Anal; 2021 Mar; 13(3):474-504. PubMed ID: 33440053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sports drug testing using complementary matrices: Advantages and limitations.
    Thevis M; Geyer H; Tretzel L; Schänzer W
    J Pharm Biomed Anal; 2016 Oct; 130():220-230. PubMed ID: 27040951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annual banned-substance review: Analytical approaches in human sports drug testing 2020/2021.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2022 Jan; 14(1):7-30. PubMed ID: 34788500
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.